A Psychedelic Treatment for Postpartum Depression? Early Findings on GH001
A small phase 2a trial of GH001, an investigational psychedelic compound, found a rapid reduction in postpartum depression symptoms. Larger studies are needed to assess safety and durability.
Essential Reads: How to Screen for Obsessive-Compulsive Symptoms in Postpartum Women?
Perinatal OCD is common but often missed by depression-only screens. Adding perinatal-specific anxiety and OCD tools can improve detection and guide targeted treatment.
Announcing our 2026 Fall NP Masterclass Cohort
Please join us in welcoming our NP Masterclass Fall 2026 cohort!
Essential Reads: Breastfeeding and ADHD Medications
Many women taking stimulants question whether it is safe to take these medications while breastfeeding. Â
Beyond Screening: Supporting the Mental Health of NICU Parents
Parents of infants in the NICU face high rates of depression, anxiety, stress, and trauma. Are we doing enough to identify their needs—and provide meaningful mental health support?
Lee Cohen, MD: Message on Maternal Suicide Awareness
In recognition of Suicide Prevention Awareness Month: A Message from Dr. Lee Cohen